Saturday, May 28, 2016 8:52:40 PM
If I was Amarantus CEO?
1. I would have cut out lympro and MS precise. Sold those assets if possible and unload them to someone else.
2. Company was built on Alzheimer's not ESS. I would have put focus on Eltoprazine for Alzheimer's ADHD, and Parkinsons LID. If they just advanced those assets they could have possibly been in phase 3 trials by now.
3. Found better financing, heck even Lincoln Park Capital, which is still not that great would have been better. Make a better deal with them, and forget about Josh Sason and his toxic cronies.
Where the heck is Gerald's father in all this? Why is he staying back not doing anything? Is he part of this rigged biotech? The board of directors need to get their heads out and remove Gerald as CEO.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM